|
Volumn 23, Issue 3, 2003, Pages 242-244
|
Enhancement of antitumor effect of cisplatin against human ovarian carcinoma cells by mifepristone in vivo.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ABORTIVE AGENT;
ANTINEOPLASTIC AGENT;
CISPLATIN;
MIFEPRISTONE;
ANIMAL;
ARTICLE;
CANCER TRANSPLANTATION;
CELL CULTURE;
CELL DIVISION;
DISEASE MODEL;
DRUG EFFECT;
DRUG POTENTIATION;
DRUG RESISTANCE;
DRUG SCREENING;
EXPERIMENTAL NEOPLASM;
FEMALE;
HUMAN;
MOUSE;
NUDE MOUSE;
OVARY TUMOR;
PATHOLOGY;
ABORTIFACIENT AGENTS, STEROIDAL;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CELL DIVISION;
CISPLATIN;
DISEASE MODELS, ANIMAL;
DRUG RESISTANCE, NEOPLASM;
DRUG SCREENING ASSAYS, ANTITUMOR;
DRUG SYNERGISM;
FEMALE;
HUMANS;
MICE;
MICE, NUDE;
MIFEPRISTONE;
NEOPLASM TRANSPLANTATION;
NEOPLASMS, EXPERIMENTAL;
OVARIAN NEOPLASMS;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0642281943
PISSN: 10002588
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|